Xu et al., 2025 - Google Patents
Topological and Morphological Membrane Dynamics in Giant Lipid Vesicles Driven by Monoolein CubosomesXu et al., 2025
View PDF- Document ID
- 13334386782444894613
- Author
- Xu Z
- Booth A
- Rappolt M
- Peckham M
- Tyler A
- Beales P
- Publication year
- Publication venue
- Angewandte Chemie
External Links
Snippet
Lipid nanoparticles have important applications as biomedical delivery platforms and broader engineering biology applications in artificial cell technologies. These emerging technologies often require changes in the shape and topology of biological or biomimetic …
- 239000012528 membrane 0 title abstract description 120
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5184—Virus capsids or envelopes enclosing drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Almgren et al. | Cryo transmission electron microscopy of liposomes and related structures | |
| US7150883B2 (en) | Self forming, thermodynamically stable liposomes and their applications | |
| Angelov et al. | Protein-containing PEGylated cubosomic particles: freeze-fracture electron microscopy and synchrotron radiation circular dichroism study | |
| Angelov et al. | Earliest stage of the tetrahedral nanochannel formation in cubosome particles from unilamellar nanovesicles | |
| Guo et al. | Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation | |
| Schubert et al. | Structural investigations on lipid nanoparticles containing high amounts of lecithin | |
| Chang et al. | Non-lamellar lipid liquid crystalline structures at interfaces | |
| Wadhwa et al. | Nanovesicles for nanomedicine: theory and practices | |
| Deák et al. | Physicochemical characterization of artificial nanoerythrosomes derived from erythrocyte ghost membranes | |
| Lim et al. | Spontaneous formation of nanometer scale tubular vesicles in aqueous mixtures of lipid and block copolymer amphiphiles | |
| Zhong et al. | Cryogenic transmission electron microscopy for direct observation of polymer and small-molecule materials and structures in solution | |
| Wang et al. | A novel phytantriol-based lyotropic liquid crystalline gel for efficient ophthalmic delivery of pilocarpine nitrate | |
| Rinaldi et al. | Decoration of nanovesicles with pH (low) insertion peptide (pHLIP) for targeted delivery | |
| US20180126353A1 (en) | Tubular and vesicular architectures formed from polymer-lipid blends and method for forming the same | |
| Patel et al. | Topical arginine solid lipid nanoparticles: Development and characterization by QbD approach | |
| Vandoolaeghe et al. | Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction | |
| Agrawal et al. | Design, characterization, and evaluation of efinaconazole loaded poly (D, L-lactide-co-glycolide) nanocapsules for targeted treatment of onychomycosis | |
| Venugopal et al. | FORMULATION DEVELOPMENT AND CHARACTERIZATION OF TEA TREE OIL LOADED ETHOSOMES. | |
| Xu et al. | Topological and Morphological Membrane Dynamics in Giant Lipid Vesicles Driven by Monoolein Cubosomes | |
| Reddy et al. | Niosomes as nanocarrier systems: a review | |
| Meikle et al. | Membrane-mimetic inverse bicontinuous cubic phase systems for encapsulation of peptides and proteins | |
| Xu et al. | Cubosome-Induced Topological Transformations in Giant Vesicles | |
| Bernasqué et al. | Transport of hydrocortisone in targeted layers of the skin by multi-lamellar liposomes | |
| Le Dévédec et al. | Drug governs the morphology of polyalkylated block copolymer aggregates | |
| Che et al. | Sustained release of nerve growth factor from highly homogenous cubosomes stabilized by β-casein with enhanced bioactivity and bioavailability |